Direct subunit-dependent multimodal 5-hydroxytryptamine(3) receptor antagonism by methadone

Tarek Z. Deeb, Douglas Sharp, Tim G. Hales (Lead / Corresponding author)

    Research output: Contribution to journalArticle

    13 Citations (Scopus)

    Abstract

    Homomeric 5-hydroxytryptamine (5-HT)(3A) and heteromeric 5-HT3AB receptors mediate rapid excitatory responses to serotonin in the central and peripheral nervous systems. The alkaloid morphine, in addition to being a mu-opioid receptor agonist, is a potent competitive inhibitor of 5-HT3 receptors. We examined whether methadone, an opioid often used to treat morphine dependence, also exhibited 5-HT3 receptor antagonist properties. Racemic (R/S)-methadone inhibited currents mediated by human homomeric 5-HT3A receptors (IC50 = 14.1 +/- 2.5 mu M). Incorporation of the 5-HT3B subunit into heteromeric 5-HT3AB receptors reduced the potency of inhibition by (R/S)methadone (IC50 = 41.1 +/- 0.9 mu M). (R/S)-Methadone also increased apparent desensitization of both 5-HT3 receptor subtypes. The inhibition of the 5-HT3A receptor was competitive; however, incorporation of the 5-HT3B subunit caused the appearance of inhibition that was insurmountable by 5-HT. In the absence of rapid desensitization, when dopamine was used as an agonist of 5-HT3AB receptors, the inhibition by (R/S)-methadone was voltage-dependent. The antagonist and desensitization-enhancing effects of (R/S)-methadone were shared by pure (R)- and (S)-methadone enantiomers, which had similar actions on 5-HT-evoked currents mediated by 5-HT3 receptors. However, (R)-methadone exhibited a larger voltage-dependent inhibition of dopamine-evoked currents mediated by 5-HT3AB receptors than did (S)-methadone. Inhibition of 5-HT3A receptors by (R/S)-methadone was not influenced by voltage. Thus, methadone displays multimodal subunit-dependent antagonism of 5-HT3 receptors.

    Original languageEnglish
    Pages (from-to)908-917
    Number of pages10
    JournalMolecular Pharmacology
    Volume75
    Issue number4
    DOIs
    Publication statusPublished - Apr 2009

    Keywords

    • N1E-115 NEUROBLASTOMA-CELLS
    • HUMAN 5-HT3A RECEPTORS
    • TYPE-3 RECEPTORS
    • MOLECULAR DETERMINANTS
    • ONDANSETRON
    • INHIBITION
    • CHANNEL
    • CNS
    • ACTIVATION
    • BLOCKADE

    Cite this

    @article{124b2b6831124e9ea901900dfaeaab81,
    title = "Direct subunit-dependent multimodal 5-hydroxytryptamine(3) receptor antagonism by methadone",
    abstract = "Homomeric 5-hydroxytryptamine (5-HT)(3A) and heteromeric 5-HT3AB receptors mediate rapid excitatory responses to serotonin in the central and peripheral nervous systems. The alkaloid morphine, in addition to being a mu-opioid receptor agonist, is a potent competitive inhibitor of 5-HT3 receptors. We examined whether methadone, an opioid often used to treat morphine dependence, also exhibited 5-HT3 receptor antagonist properties. Racemic (R/S)-methadone inhibited currents mediated by human homomeric 5-HT3A receptors (IC50 = 14.1 +/- 2.5 mu M). Incorporation of the 5-HT3B subunit into heteromeric 5-HT3AB receptors reduced the potency of inhibition by (R/S)methadone (IC50 = 41.1 +/- 0.9 mu M). (R/S)-Methadone also increased apparent desensitization of both 5-HT3 receptor subtypes. The inhibition of the 5-HT3A receptor was competitive; however, incorporation of the 5-HT3B subunit caused the appearance of inhibition that was insurmountable by 5-HT. In the absence of rapid desensitization, when dopamine was used as an agonist of 5-HT3AB receptors, the inhibition by (R/S)-methadone was voltage-dependent. The antagonist and desensitization-enhancing effects of (R/S)-methadone were shared by pure (R)- and (S)-methadone enantiomers, which had similar actions on 5-HT-evoked currents mediated by 5-HT3 receptors. However, (R)-methadone exhibited a larger voltage-dependent inhibition of dopamine-evoked currents mediated by 5-HT3AB receptors than did (S)-methadone. Inhibition of 5-HT3A receptors by (R/S)-methadone was not influenced by voltage. Thus, methadone displays multimodal subunit-dependent antagonism of 5-HT3 receptors.",
    keywords = "N1E-115 NEUROBLASTOMA-CELLS, HUMAN 5-HT3A RECEPTORS, TYPE-3 RECEPTORS, MOLECULAR DETERMINANTS, ONDANSETRON, INHIBITION, CHANNEL, CNS, ACTIVATION, BLOCKADE",
    author = "Deeb, {Tarek Z.} and Douglas Sharp and Hales, {Tim G.}",
    year = "2009",
    month = "4",
    doi = "10.1124/mol.108.053322",
    language = "English",
    volume = "75",
    pages = "908--917",
    journal = "Molecular Pharmacology",
    issn = "0026-895X",
    publisher = "American Society for Pharmacology and Experimental Therapeutics",
    number = "4",

    }

    Direct subunit-dependent multimodal 5-hydroxytryptamine(3) receptor antagonism by methadone. / Deeb, Tarek Z.; Sharp, Douglas; Hales, Tim G. (Lead / Corresponding author).

    In: Molecular Pharmacology, Vol. 75, No. 4, 04.2009, p. 908-917.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Direct subunit-dependent multimodal 5-hydroxytryptamine(3) receptor antagonism by methadone

    AU - Deeb, Tarek Z.

    AU - Sharp, Douglas

    AU - Hales, Tim G.

    PY - 2009/4

    Y1 - 2009/4

    N2 - Homomeric 5-hydroxytryptamine (5-HT)(3A) and heteromeric 5-HT3AB receptors mediate rapid excitatory responses to serotonin in the central and peripheral nervous systems. The alkaloid morphine, in addition to being a mu-opioid receptor agonist, is a potent competitive inhibitor of 5-HT3 receptors. We examined whether methadone, an opioid often used to treat morphine dependence, also exhibited 5-HT3 receptor antagonist properties. Racemic (R/S)-methadone inhibited currents mediated by human homomeric 5-HT3A receptors (IC50 = 14.1 +/- 2.5 mu M). Incorporation of the 5-HT3B subunit into heteromeric 5-HT3AB receptors reduced the potency of inhibition by (R/S)methadone (IC50 = 41.1 +/- 0.9 mu M). (R/S)-Methadone also increased apparent desensitization of both 5-HT3 receptor subtypes. The inhibition of the 5-HT3A receptor was competitive; however, incorporation of the 5-HT3B subunit caused the appearance of inhibition that was insurmountable by 5-HT. In the absence of rapid desensitization, when dopamine was used as an agonist of 5-HT3AB receptors, the inhibition by (R/S)-methadone was voltage-dependent. The antagonist and desensitization-enhancing effects of (R/S)-methadone were shared by pure (R)- and (S)-methadone enantiomers, which had similar actions on 5-HT-evoked currents mediated by 5-HT3 receptors. However, (R)-methadone exhibited a larger voltage-dependent inhibition of dopamine-evoked currents mediated by 5-HT3AB receptors than did (S)-methadone. Inhibition of 5-HT3A receptors by (R/S)-methadone was not influenced by voltage. Thus, methadone displays multimodal subunit-dependent antagonism of 5-HT3 receptors.

    AB - Homomeric 5-hydroxytryptamine (5-HT)(3A) and heteromeric 5-HT3AB receptors mediate rapid excitatory responses to serotonin in the central and peripheral nervous systems. The alkaloid morphine, in addition to being a mu-opioid receptor agonist, is a potent competitive inhibitor of 5-HT3 receptors. We examined whether methadone, an opioid often used to treat morphine dependence, also exhibited 5-HT3 receptor antagonist properties. Racemic (R/S)-methadone inhibited currents mediated by human homomeric 5-HT3A receptors (IC50 = 14.1 +/- 2.5 mu M). Incorporation of the 5-HT3B subunit into heteromeric 5-HT3AB receptors reduced the potency of inhibition by (R/S)methadone (IC50 = 41.1 +/- 0.9 mu M). (R/S)-Methadone also increased apparent desensitization of both 5-HT3 receptor subtypes. The inhibition of the 5-HT3A receptor was competitive; however, incorporation of the 5-HT3B subunit caused the appearance of inhibition that was insurmountable by 5-HT. In the absence of rapid desensitization, when dopamine was used as an agonist of 5-HT3AB receptors, the inhibition by (R/S)-methadone was voltage-dependent. The antagonist and desensitization-enhancing effects of (R/S)-methadone were shared by pure (R)- and (S)-methadone enantiomers, which had similar actions on 5-HT-evoked currents mediated by 5-HT3 receptors. However, (R)-methadone exhibited a larger voltage-dependent inhibition of dopamine-evoked currents mediated by 5-HT3AB receptors than did (S)-methadone. Inhibition of 5-HT3A receptors by (R/S)-methadone was not influenced by voltage. Thus, methadone displays multimodal subunit-dependent antagonism of 5-HT3 receptors.

    KW - N1E-115 NEUROBLASTOMA-CELLS

    KW - HUMAN 5-HT3A RECEPTORS

    KW - TYPE-3 RECEPTORS

    KW - MOLECULAR DETERMINANTS

    KW - ONDANSETRON

    KW - INHIBITION

    KW - CHANNEL

    KW - CNS

    KW - ACTIVATION

    KW - BLOCKADE

    UR - http://www.scopus.com/inward/record.url?scp=63849116222&partnerID=8YFLogxK

    U2 - 10.1124/mol.108.053322

    DO - 10.1124/mol.108.053322

    M3 - Article

    VL - 75

    SP - 908

    EP - 917

    JO - Molecular Pharmacology

    JF - Molecular Pharmacology

    SN - 0026-895X

    IS - 4

    ER -